The C20orf133 gene is disrupted in a patient with Kabuki syndrome

被引:52
作者
Maas, Nicole M. C.
de Putte, Tom Van
Melotte, Cindy
Francis, Annick
Schrander-Stumpel, Constance T. R. M.
Sanlaville, Damien
Genevieve, David
Lyonnet, Stanislas
Dimitrov, Boyan
Devriendt, Koenraad
Fryns, Jean-Pierre
Vermeesch, Joris R.
机构
[1] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Dept Human Genet, Div Mol & Dev Genet, Lab Mol Biol Celgen, Louvain, Belgium
[3] Dept Mol & Dev Genet VIB, Louvain, Belgium
[4] Maastricht Univ, Acad Hosp Maastricht, Dept Clin Genet, Maastricht, Netherlands
[5] Maastricht Univ, Res Inst GROW, Maastricht, Netherlands
[6] Hop Necker Enfants Malad, Dept Genet, AP HP, Paris, France
基金
英国惠康基金;
关键词
D O I
10.1136/jmg.2007.049510
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Kabuki syndrome (KS) is a rare, clinically recognisable, congenital mental retardation syndrome. The aetiology of KS remains unknown. Methods: Four carefully selected patients with KS were screened for chromosomal imbalances using array comparative genomic hybridisation at 1 Mb resolution. Results: In one patient, a 250 kb de novo microdeletion at 20p12.1 was detected, deleting exon 5 of C20orf133. The function of this gene is unknown. In situ hybridisation with the mouse orthologue of C20orf133 showed expression mainly in brain, but also in kidney, eye, inner ear, ganglia of the peripheral nervous system and lung. Conclusion: The de novo nature of the deletion, the expression data and the fact that C20orf133 carries a macro domain, suggesting a role for the gene in chromatin biology, make the gene a likely candidate to cause the phenotype in this patient with KS. Both the finding of different of chromosomal rearrangements in patients with KS features and the absence of C20orf133 mutations in 19 additional patients with KS suggest that KS is genetically heterogeneous.
引用
收藏
页码:562 / 569
页数:8
相关论文
共 62 条
[1]   Kabuki syndrome: a review [J].
Adam, MP ;
Hudgins, L .
CLINICAL GENETICS, 2005, 67 (03) :209-219
[2]   Further delineation of Kabuki syndrome in 48 well-defined new individuals [J].
Armstrong, L ;
El Moneim, AA ;
Aleck, K ;
Aughton, DJ ;
Baumann, C ;
Braddock, SR ;
Gillessen-Kaesbach, G ;
Graham, JM ;
Grebe, TA ;
Gripp, KW ;
Hall, BD ;
Hennekam, R ;
Hunter, A ;
Keppler-Noreuil, K ;
Lacombe, D ;
Lin, AE ;
Ming, JE ;
Kokitsu-Nakata, NM ;
Nikkel, SM ;
Philip, N ;
Raas-Rothschild, A ;
Sommer, A ;
Verloes, A ;
Walter, C ;
Wieczorek, D ;
Williams, MS ;
Zackai, E ;
Allanson, JE .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2005, 132A (03) :265-272
[3]   No major contribution of the TGFBR1- and TGFBR2-mediated pathway to Kabuki syndrome [J].
Bottani, A ;
Pardo, B ;
Bouchardy, I ;
Schoumans, J ;
Toutain, A ;
Conrad, B .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (08) :903-905
[4]  
Courtens W, 2000, AM J MED GENET, V93, P244, DOI 10.1002/1096-8628(20000731)93:3<244::AID-AJMG17>3.0.CO
[5]  
2-2
[6]   Allele frequency data for 19 short tandem repeats (PowerPlex® 16 and FFFI) in a Belgian population sample [J].
Decorte, R ;
Verhoeven, E ;
Vanhoutte, E ;
Knaepen, K ;
Cassiman, JJ .
JOURNAL OF FORENSIC SCIENCES, 2006, 51 (02) :436-437
[7]   Belgian population data for 15 STR loci (AmpFlSTR® SGM Plus and AmpFlSTR™ profiler PCR amplification kit) [J].
Decorte, R ;
Engelen, M ;
Larno, L ;
Nelissen, K ;
Gilissen, A ;
Cassiman, JJ .
FORENSIC SCIENCE INTERNATIONAL, 2004, 139 (2-3) :211-213
[8]   3 PATIENTS WITH RING (X)-CHROMOSOMES AND A SEVERE PHENOTYPE [J].
DENNIS, NR ;
COLLINS, AL ;
CROLLA, JA ;
COCKWELL, AE ;
FISHER, AM ;
JACOBS, PA .
JOURNAL OF MEDICAL GENETICS, 1993, 30 (06) :482-486
[9]  
Donadio A, 2000, AM J MED GENET, V91, P164, DOI 10.1002/(SICI)1096-8628(20000313)91:2<164::AID-AJMG19>3.3.CO
[10]  
2-5